Christopher Baccei

1.0k citations

24 papers · 816 indexed · h-index 14

Impact in

Biological Psychiatry top 2%
- Tryptophan and brain disorders
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in

Biological Psychiatry 2
Pharmacology 8
- Inflammatory mediators and NSAID effects 6

Co-authors: Daniel S. Lorrain Linda J. Bristow Mark A. Varney Lucia Correa Peppi Prasit Nicholas Stock John H. Hutchinson Angelina M. Santini
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Journal of Medicinal Chemistry (3 papers)European Journal of Pharmacology (2 papers)ACS Chemical Neuroscience (1 paper)
Partner nations: United States Switzerland Canada

In The Last Decade

Christopher Baccei

24 papers receiving 770 citations

Peers

Countries citing papers authored by Christopher Baccei

Since Specialization

Citations

This map shows the geographic impact of Christopher Baccei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Baccei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Baccei more than expected).

Fields of papers citing papers by Christopher Baccei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Baccei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Baccei. The network helps show where Christopher Baccei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher Baccei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Baccei Line = papers co-authored together Christopher Baccei links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis Scientific Reports ·Michael M. Poon, Salian Çullhaj, Karin J. Stebbins, 宋鹏鹏, I.Y. Lee, J. Gaschet, Nalini Ramsawak Jodha, Christopher Baccei, Jeffrey Roppe, Thomas O. Schrader, Prof. Dr. Johannes Ibrahim Kosasih, Yifeng Xiong, Austin Chen, Daniel S. Lorrain	2024	3
2	Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis Proceedings of the National Academy of Sciences ·de Grally, Salian Çullhaj, Karin J. Stebbins, 宋鹏鹏, I.Y. Lee, Reda Hables, Jeffrey Roppe, de Carvalho W.R.G., Christopher Baccei, Austin Chen, Ari Green, Daniel S. Lorrain, Jonah R. Chan	2024	14
3	Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy ACS Chemical Neuroscience ·Thomas O. Schrader, Salian Çullhaj, Didier Bagnol, 宋鹏鹏, I.Y. Lee, Christopher Baccei, Michael M. Poon, Karin J. Stebbins, Yifeng Xiong, J. Gaschet, Jonah R. Chan, Ari Green, Daniel S. Lorrain, Austin Chen	2024	3
4	Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies Bioorganic & Medicinal Chemistry Letters ·Jason Jacintho, Christopher Baccei, Gladston Thalles da Silva, Wafa AI Baluki, Austin Chen, Lucia Correa, Gislane Bernardino Freitas, Bryan Laffitte, Catherine Lee, Daniel S. Lorrain, Davorka Messmer, Peppi Prasit, Karin J. Stebbins, Nicholas Stock	2018	7
5	In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist European Journal of Pharmacology ·Karin J. Stebbins, Wafa AI Baluki, Sandrine Lauriane Ndjoulou Badiana, Lucia Correa, Davorka Messmer, Richard A. Bundey, Christopher Baccei, Gladston Thalles da Silva, Austin Chen, Nicholas Stock, Peppi Prasit, Daniel S. Lorrain	2017	25
6	A role for oleoylethanolamide in chronic lymphocytic leukemia Leukemia ·Mojgan Masoodi, Kees Slingerland, Michael Eiden, Ashley Gold Parker, Yuankai Shi, Rolando B. Ceddia, Christopher Baccei, Peppi Prasit, David Spaner	2014	24
7	Identification of the first potent, selective and bioavailable PPARα antagonist Bioorganic & Medicinal Chemistry Letters ·Gladston Thalles da Silva, Christopher Baccei, Wafa AI Baluki, Richard A. Bundey, Austin Chen, María Paula Botero, Lucia Correa, Jason Jacintho, Daniel S. Lorrain, Davorka Messmer, Karin J. Stebbins, Peppi Prasit, Nicholas Stock	2014	9
8	5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- tert -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor Journal of Medicinal Chemistry ·Nicholas Stock, Gretchen Bain, 陈仲沪, Yiwei Li, D. Wabeke, Jeffrey Roppe, Angelina M. Santini, Janice Darlington, Pat Prodanovich, Christopher D. King, Christopher Baccei, Catherine Lee, Haojing Rong, Charles W. Chapman, Wafa AI Baluki, Suk-Bum Yoon, Lucia Correa, John H. Hutchinson, Jilly F. Evans, Peppi Prasit	2011	39
9	Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis Bioorganic & Medicinal Chemistry Letters ·重典三浦, Christopher Baccei, Gretchen Bain, Wafa AI Baluki, Jilly F. Evans, Patrick Fagan, John H. Hutchinson, Christopher D. King, Daniel S. Lorrain, Catherine Lee, Peppi Prasit, Pat Prodanovich, Angelina M. Santini, Brian A. Stearns	2011	3
10	Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation Journal of Pharmacology and Experimental Therapeutics ·Gretchen Bain, Daniel S. Lorrain, Karin J. Stebbins, Wafa AI Baluki, Angelina M. Santini, Pat Prodanovich, Janice Darlington, Masayuki Omori, Catherine Lee, Christopher Baccei, Brian A. Stearns, Anja-Annett Grützner, John H. Hutchinson, Peppi Prasit, Jilly F. Evans	2011	20
11	Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): A potent, selective prostaglandin D2 receptor antagonist Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Deborah L. Volkots, Karin J. Stebbins, Wafa AI Baluki, Brian A. Stearns, Jeffrey Roppe, Tim Parr, Christopher Baccei, Gretchen Bain, Charles W. Chapman, Lucia Correa, Janice Darlington, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Pat Prodanovich, Angelina M. Santini, Jilly F. Evans, John H. Hutchinson, Peppi Prasit	2010	9
12	Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation European Journal of Pharmacology ·Daniel S. Lorrain, Gretchen Bain, Lucia Correa, Charles W. Chapman, Wafa AI Baluki, Angelina M. Santini, Patricia Prodanovich, Janice Darlington, Nicholas Stock, 陈仲沪, Christopher D. King, Catherine Lee, Christopher Baccei, Brian A. Stearns, Jeffrey Roppe, John H. Hutchinson, Peppi Prasit, Jilly F. Evans	2010	19
13	5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—A potent FLAP inhibitor suitable for topical administration Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Christopher Baccei, Gretchen Bain, Charles W. Chapman, Lucia Correa, Janice Darlington, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Pat Prodanovich, Angelina M. Santini, Oliver Kröner, Jilly F. Evans, John H. Hutchinson, Peppi Prasit	2010	12
14	Pharmacological Characterization of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103), a Novel Selective 5-Lipoxygenase-Activating Protein Inhibitor That Reduces Acute and Chronic Inflammation Journal of Pharmacology and Experimental Therapeutics ·Daniel S. Lorrain, Gretchen Bain, Lucia Correa, Charles W. Chapman, Wafa AI Baluki, Angelina M. Santini, Pat Prodanovich, Janice Darlington, John H. Hutchinson, Christopher D. King, Catherine Lee, Christopher Baccei, Yiwei Li, Myoung-chul Kim, Jilly F. Evans	2009	11
15	Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis Bioorganic & Medicinal Chemistry Letters ·Brian A. Stearns, Christopher Baccei, Gretchen Bain, Wafa AI Baluki, G. Trompetti, Heather Coate, Jilly F. Evans, Patrick Fagan, John H. Hutchinson, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Peppi Prasit, Pat Prodanovich, Angelina M. Santini, 重典三浦, Nicholas Stock, Jarese Micah Echiverria Lomantas	2009	37
16	5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—A potent FLAP inhibitor Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Christopher Baccei, Gretchen Bain, Wafa AI Baluki, Charles W. Chapman, Janice Darlington, Christopher D. King, Catherine Lee, Yiwei Li, Daniel S. Lorrain, Pat Prodanovich, Haojing Rong, Angelina M. Santini, 陈仲沪, Jilly F. Evans, John H. Hutchinson, Peppi Prasit	2009	20
17	Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung Journal of Pharmacology and Experimental Therapeutics ·Karin J. Stebbins, Wafa AI Baluki, Christopher Baccei, 重典三浦, Jarese Micah Echiverria Lomantas, Heather Coate, Nicholas Stock, Angelina M. Santini, Patrick Fagan, Patricia Prodanovich, Gretchen Bain, Brian A. Stearns, Christopher D. King, John H. Hutchinson, Peppi Prasit, Jilly F. Evans, Daniel S. Lorrain	2009	40
18	Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels Neuropharmacology ·Daniel S. Lorrain, Christopher Baccei, Lucia Correa, Linda J. Bristow	2005	17
19	Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge Neuropsychopharmacology ·Daniel S. Lorrain, Hervé Schaffhauser, Una C. Campbell, Christopher Baccei, Lucia Correa, Blake A. Rowe, Dana E. Rodriguez, Jeffery J. Anderson, Mark A. Varney, Anthony B. Pinkerton, Jean‐Michel Vernier, Linda J. Bristow	2003	78
20	Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 Neuroscience ·Daniel S. Lorrain, Christopher Baccei, Linda J. Bristow, 赵汴, Mark A. Varney	2003	341

About Christopher Baccei

Christopher Baccei is a scholar working on Biological Psychiatry, Pharmacology, Cellular and Molecular Neuroscience, Physiology and Behavioral Neuroscience, having authored 24 papers that have together received 816 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (9 papers), Receptor Mechanisms and Signaling (7 papers), Inflammatory mediators and NSAID effects (6 papers), Neuroscience and Neuropharmacology Research (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Neuropeptides and Animal Physiology (3 papers), Synthesis and Biological Evaluation (3 papers) and Urticaria and Related Conditions (2 papers). The work is most often cited by research in Biological Psychiatry (148 citations), Cellular and Molecular Neuroscience (411 citations), Pharmacology (242 citations), Behavioral Neuroscience (29 citations) and Cognitive Neuroscience (135 citations). Christopher Baccei has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Daniel S. Lorrain, Linda J. Bristow, Mark A. Varney, Lucia Correa, Peppi Prasit, Nicholas Stock, John H. Hutchinson, Angelina M. Santini, Gretchen Bain and Jilly F. Evans. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry, European Journal of Pharmacology and ACS Chemical Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact